Identification of PP2A/Set Binding Sites and Design of Interacting Peptides with Potential Clinical Applications

about

Identification of PP2A/Set Binding Sites and Design of Interacting Peptides with Potential Clinical Applications

Item

http://www.wikidata.org/entity/Q58374470

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2017

@uk

name

Identification of PP2A/Set Bin ...... otential Clinical Applications

@en

Identification of PP2A/Set Bin ...... otential Clinical Applications

@nl

type

Item

label

Identification of PP2A/Set Bin ...... otential Clinical Applications

@en

Identification of PP2A/Set Bin ...... otential Clinical Applications

@nl

prefLabel

Identification of PP2A/Set Bin ...... otential Clinical Applications

@en

Identification of PP2A/Set Bin ...... otential Clinical Applications

@nl

P1476

Identification of PP2A/Set Bin ...... otential Clinical Applications

@en

P2093

Angelita Rebollo

http://www.w3.org/2001/XMLSchema#string

Dorien Haesen

http://www.w3.org/2001/XMLSchema#string

Etienne Waelkens

http://www.w3.org/2001/XMLSchema#string

Jean Marc Zini

http://www.w3.org/2001/XMLSchema#string

Jeronimo Bravo

http://www.w3.org/2001/XMLSchema#string

Jesus Fominaya

http://www.w3.org/2001/XMLSchema#string

Lu Tian

http://www.w3.org/2001/XMLSchema#string

Severine Loisel

http://www.w3.org/2001/XMLSchema#string

Sylvain Choquet

http://www.w3.org/2001/XMLSchema#string

Veerle Janssens

http://www.w3.org/2001/XMLSchema#string

P2860

The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A

Identification of PP2A complexes and pathways involved in cell transformation

The Basic Biology of PP2A in Hematologic Cells and Malignancies

Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A

FTY720 induces apoptosis of M2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels

Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein.

Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer

From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies

Rules for making human tumor cells.

Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapy

P2888

s10989-017-9633-1

P304

479-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10989-017-9633-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921